Skip to main content

Advertisement

Figure 1 | Diabetology & Metabolic Syndrome

Figure 1

From: Current european regulatory perspectives on insulin analogues

Figure 1

Co-opted members: members who provide additional expertise in a particular scientific area - i.e.: medical statistics; pharmacovigilance, pharmacoepidemiology; quality (non-biologicals), quality and safety (biological), with expertise in advanced therapies (gene, cell and tissue therapies). Delegates: CHMP members and alternates nominated by each of the EU-member states in consultation with the EMA Management Board. EEA: European Economic Area: Member States of the EU + 2 delegates from Iceland and Norway.

Back to article page